Saturday 17 October 2026
Export ALUR’s income statement to Excel — free account
Allurion Technologies, Inc.
ALUR Healthcare Medical Devices
Allurion Technologies, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $15.2 million, down 52.6% from fiscal 2024. In the quarter to March 2026, revenue fell 47.2%, EPS fell 46.5% and free cash flow grew 66.0%, each against the same quarter a year earlier.
0.48
0.12
−20.00%
Follow ALUR
Allurion Technologies, Inc. (ALUR) P/E ratio
Allurion Technologies, Inc. has no meaningful P/E ratio: its trailing twelve-month earnings is negative. Over the past ten years it has ranged from 0.0× (October 2026) to 2.4× (March 2022) — the current reading is the lowest in ten years.
P/E ratio, daily
Embed this chart
Annual newest first
| Period | P/E ratio | Change |
|---|---|---|
| FY2025 | 0.0× | — |
| FY2024 | 0.0× | — |
| FY2023 | 0.0× | — |
| FY2022 | 0.0× | — |
Quarterly newest first
| Period | P/E ratio | Change |
|---|---|---|
| Mar 2026 | 0.0× | — |
| Dec 2025 | 0.0× | — |
| Sep 2025 | 0.0× | — |
| Jun 2025 | 0.0× | — |
| 12 more quarters | Free account |
Against its own ten years
Low 0.0×
High 2.4×
Ten-year median
0.0×
Current reading's percentile
84
P/E ratio against peers
| Company | P/E ratio |
|---|---|
| RBOT Vicarious Surgical Inc. compare | n/m |
| LFWD Lifeward Ltd. compare | n/m |
| MODD Modular Medical, Inc. compare | n/m |
| PAVM PAVmed Inc. compare | n/m |
| ALUR Allurion Technologies, Inc. | n/m |
| IRIX IRIDEX Corporation compare | n/m |
| ARAY Accuray Incorporated compare | n/m |
| BDMD Baird Medical Investment Holdings Limited compare | n/m |
| HSCS HeartSciences Inc. compare | n/m |
| Medical Devices industry median | 23.2× |
| Healthcare sector median | 23.0× |
| Market median | 18.1× |
What P/E ratio is
Price to Earnings Ratio shows how much investors pay for each dollar of a company’s annual profit per share.
Stock Price ÷ EPS (Basic) (TTM)